一名65岁男子在几十年严重出血后,终于被确诊患有冯·威勒布兰德病,现在,他以无血浆治疗有效地管理了这一疾病。 A 65-year-old man finally diagnosed with von Willebrand disease after decades of severe bleeding, now manages it effectively with a plasma-free treatment.

Frank, 65岁男子, 终于被确诊为Von Willebrand病(VWD), 这是美国最常见的出血紊乱症, Frank, a 65-year-old man, was finally diagnosed with von Willebrand disease (VWD), the most common bleeding disorder in the U.S., after decades of unexplained severe nosebleeds and life-threatening gastrointestinal bleeds. 他的病情历经多年未诊断,导致经常住院和输血并发症。 His condition, which went undiagnosed for years, led to frequent hospitalizations and complications from blood transfusions. 2013年,一家家庭诊断促使检测证实VWD。 In 2013, a family diagnosis prompted testing that confirmed VWD. 他开始使用VONVENDI治疗,VONVENDI是一种重新组合的Von Willebrand因子疗法,经批准可按需使用,在成人中进行手术性预防和预防。 He began treatment with VONVENDI, a recombinant von Willebrand factor therapy approved for on-demand use, perioperative prevention, and prophylaxis in adults. 这种治疗在没有人类等离子体的情况下进行,帮助他有效地管理出血并恢复控制,尽管病情具有终身的性质,但提供了新的稳定性。 The treatment, made without human plasma, helped him manage bleeds effectively and regain control, offering new stability despite the condition’s lifelong nature.